feed,title,long_url,short_url
Benzinga,"Mesoblast Shares Tumble As FDA Strikes Out Cell Therapy Application For Children Again, Requires Additional Trial",https://benzinga.com/analyst-ratings/analyst-color/23/08/33571293/mesoblast-shares-tumble-as-fda-strikes-out-cell-therapy-application-for-children-ag,https://da.gd/yy0ce
